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and are uncertain about why community 
members are dying from what appear to the 
survivors to be unusual causes. Although 
Hrudey may feel this concern is misplaced or 
unfounded, that opinion does not reflect the 
feelings of those who live in Fort Chipewyan. 
The Alberta government’s assertion that 
more extensive health studies are warranted 
(Chen 2009) and stated intention to actively 
pursue such studies (Weinhold 2011) suggest 
adverse health effects are at least plausible. 
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Neurotoxicity of PBDEs on the 
Developing Nervous System
doi:10.1289/ehp.1103907
Dingemans et al. (2011) published a review 
article on polybrominated diphenyl ethers 
(PBDEs) and the developing nervous system. 
However, the authors summarized but failed 
to criti  cally evaluate the articles cited in their 
review. They also did not discuss or cite litera-
ture that contradicted the studies on which 
they based their conclusions. For example, 
the U.S. Environmental Protection Agency 
(EPA) cosponsored an expert panel on neuro-
develop  mental end points, which concluded 
that an experimental design used in nine of 
the studies cited by Dingemans et al. (2011) 
failed to control for litter effects (Holson et al. 
2008). 
Although some investigators have set 
forth the argument that direct dosing of 
pups precludes the need to control for litter 
effects, a U.S. EPA cosponsored expert panel 
(Moser et al. 2005) evaluated this issue and 
concluded otherwise. 
Regardless of whether Dingemans et al. 
(2011) view the studies by Holson et al. 
(2008) and Moser et al. (2005) as cred-
ible, the authors should have discussed them 
to some degree. It is understandable that 
because of space limitations not all studies 
can be included in a review. However, it was 
unacceptable to exclude studies that carry 
the weight of U.S. EPA cosponsored expert 
panels or other reviews that critically evalu-
ated many of the studies cited by Dingemans 
et al. (2011) (e.g., Goodman 2009; Hardy 
et al. 2009; Williams and DeSesso 2010) 
and came to opposite conclusions. 
Although the article by Dingemans et al. 
(2011) was peer-reviewed, it presents informa-
tion in a selective, noncritical manner, which 
is best reserved for public relation pieces com-
municated in the non–peer-reviewed media. 
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Banasik and Suchecka express their discon-
tent with our recent review on the (in-)direct 
neurotoxic effects of parent and hydrox  ylated 
(OH-) polybrominated diphenyl ethers 
(PBDEs) on the (developing) nervous sys-
tem (Dingemans et al. 2011). Their main 
discontent appears to be once more related 
to the experi  mental design in a number of 
cited behavioral studies. However, our aim 
was to identify and review the mecha  nisms 
under  lying the observed adverse (behavioral) 
effects, not to evaluate the experimental 
design of behavioral studies within a regula-
tory setting. Nonetheless, approximately 10% 
of our review was dedicated to describing a 
number of behavioral studies [12 different 
studies from seven different research groups, 
including a 2008 EPA study (Gee and Moser 
2008)] that all indicated the occurrence of 
neuro  behavioral effects following develop-
mental exposure to PBDEs. We used this 
information to create a starting point for the 
main part of our review of direct and indirect 
cellular and molecular mechanisms. For read-
ability and space limitations, we were not 
able to include all studies, concerns, or cri-
tiques that have ever been raised. The absence 
of a citation to a particular study does not 
mean that we regard it as less credible.
The view that (developmental) exposure 
to PBDEs induces adverse neuro  toxic effects 
is widely supported by numerous in vivo, 
ex vivo, and in vitro studies reporting both 
structural and functional effects (Dingemans 
et al. 2011). For some time, a lively discus-
sion has been taking place within the scien-
tific community on the experimental design 
for behavioral developmental neuro  toxicity 
studies for regulatory purposes, in particular 
considering the statistical unit (Alcock et al. 
2011). In short, there is disagreement about 
whether direct dosing of pups precludes 
the need to control for litter effects (e.g., 
Eriksson 2008; Hardy and Stedeford 2008). 
However, we did not address this topic in 
our paper because we consider the potential 
occurrence of a litter effect to be irrele  vant for 
the reviewed cellular and molecular in vitro 
studies, which all indicate that exposure to 
PBDEs induces neurotoxic effects.
Critical remarks can be found through-
out our review (Dingemans et al. 2011), but 
they are related to cellu  lar and molecular 
findings, data gaps, or aspects that warrant 
further investigation. Our main conclusions 
are related to the specific (developmental) 
neuro  toxic hazard of OH-PBDEs compared 
with that of their parent congeners via direct 
neuro  toxicity and thyroid disruption. We also 
pointed out the need to further investigate the 
impact of active metabolites, concentrations 
of PBDEs and metabolites in the (developing) 
brain, and the potentially increased neuro-
toxic hazard following exposure to mixtures 
of different environmental contaminants.
Nonetheless, Banasik and Suchecka raise 
an important issue: the existence of differences 
in experimental designs for in vivo investi-
gation of (developmental) neuro  toxicity. 
Differences exist in the selection of investi-
gated end points and also in methodologies 
for the investigation of a specific end point, 
as reviewed for effects on motor activity by 
brominated flame retardants (Williams and 
DeSesso 2010). These differences in experi-Correspondence
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mental design may under  lie observed differ-
ences in sensitivity to detect neuro  toxicity, 
possibly because of differences in bio  kinetics 
and exposure during sensitive windows of 
development. Fortunately, much effort is tak-
ing place in the scientific community to opti-
mize experi  mental designs at different levels 
of biological complexity, including (develop-
mental) neuro  behavioral studies. Although 
a critical review on the impact of different 
experi  mental designs for in vivo (developmen-
tal) neuro  toxicity studies would be very use-
ful, it was beyond the scope of our review 
(Dingemans et al. 2011). 
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Three Criteria for Ecological Fallacy
doi:10.1289/ehp.1103768
In a large cohort study published in 
Environmental Health Perspectives, Brenner 
et al. (2011) confirmed previous results on 
I-131 exposure and thyroid cancer among 
a Ukranian population. According to 
the authors, one motivation to study this 
associa  tion was based on evidence from eco-
logical studies (Jacob et al. 1999) with two 
methodo  logical limitations: use of grouped 
doses and poor control of confounding. 
With these new findings, evidence from eco-
logical, case–control, and cohort studies are 
consistent; thus, an interesting question is 
whether there was an ecological fallacy.
Although ecological studies are important 
to epidemiology (especially in environmental 
and social epidemiology), public health prac-
titioners seem afraid of ecological studies. It is 
a common practice to assume the presence of 
ecological fallacy (Robinson 1950) and low-
level validity when analyzing an ecological 
study. Most epidemiologists prefer an exclu-
sive individualistic approach, although the 
importance of a multi  level causal approach 
is widely recognized (Diez-Roux 2002). In 
this sense, some authors suggest that it is as 
important to recognize the presence of eco-
logical fallacy as to recognize psychologistic 
or individualistic fallacy (Subramanian et al. 
2009) (Figure 1).
Thus, it is necessary to have clear guide-
lines on when there is or not an ecological 
fallacy. In this sense, I propose three criteria 
for the identification of ecological fallacy; all 
three of these should be present to confirm 
its existence: 
•	Results	must	be	obtained	with	ecological	
(population) data.
•	Data	must	be	inferred	to	individuals.	
One use of ecological studies is to explore   
individual-level association when individual 
data are not available. When the focus of 
the study was contextual or based on popu-
la  tion effects and there is no inference to 
individuals, ecological fallacy is not pos-
sible. When only the first two criteria are 
present—which is insufficient to affirm eco-
logical fallacy—it is appropriate to acknowl-
edge that there is a possible relation  ship and 
that further study is required. 
•	Results	obtained	with	individual	data	are	
contradictory. 
Only when empirical data are available is 
it possible to confirm that an ecological fallacy 
is present. 
The author declares that he has no competing 
financial interests.
Alvaro J. Idrovo
Center for Health Systems Research
National Institute of Public Health
Cuernavaca, Morelos, Mexico 
E-mail: javier.idrovo@insp.mx
RefeRences
Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, 
Lubin JH, et al. 2011. I-131 dose response for incident 
thyroid cancers in Ukraine related to the Chornobyl acci-
dent. Environ Health Perspect 119:933–939; doi:10.1289/
ehp.1002674 [Online 17 March 2011].
Diez-Roux AV. 2002. A glossary for multilevel analysis. 
J Epidemiol Community Health 56(8):588–594.
Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, 
Heidenreich WF, et al. 1999. Childhood exposure due 
to the Chernobyl accident and thyroid cancer risk in 
contaminated areas of Belarus and Russia. Br J Cancer 
80(9):1461–1469.
Robinson WS. 1950. Ecological correlations and the behavior 
of individuals. Am Sociol Rev 15(3):351–357.
Subramanian SV, Jones K, Kaddour A, Krieger N. 2009. 
Revisiting Robinson: the perils of individualistic and eco-
logic fallacy. Int J Epidemiol 38(2):342–360.
Carbon Black
doi:10.1289/ehp.1103444
In “Research Recommendations for Selected 
IARC-Classified Agents,” Ward et al. (2010) 
identified research gaps for 20 occupational 
agents “based on evidence of widespread 
human exposures and potential carcino-
genicity in animals or humans.” (Ward 
et al. 2010) For carbon black, the authors   
suggested that
Research needs include updating epidemiology 
cohorts with data on work histories and exposures 
in relation to particle size and surface area, and 
recruitment of additional carbon black facilities. 
The relationship between occupational exposure 
to carbon black and validated bio  markers of oxi-
dative stress should be examined and exposure–
response relationships in humans and rodents 
quantified, including the role of particle size. 
Ward et al. (2010) referred to a study of 
British carbon black workers in which carbon 
black was suggested as a possible “late stage 
carcinogen” (Sorahan and Harrington 2007). 
In that study, Sorahan and Harrington 
(2007) called for similar analyses of other 
carbon black cohorts (i.e., evaluating the 
possibility of carbon black acting as a late 
stage carcinogen via the concept of “lugging,” 
which considers only recent exposures and 
not historical exposures). In response to sug-
gestions made by Sorahan and Harrington, 
we conducted such analyses on a large 
German carbon black cohort (Morfeld and 
McCunney 2007, 2009). We were unable to 
reproduce the results of the British analysis, 
despite the elevation noted in lung cancer 
among German cohort workers, thus pro-
viding no support for the late stage-lugging 
hypothesis. Results of a detailed analysis of 
the German cohort using Bayesian meth-
odology showed smoking and exposure to 
occupational carcinogens prior to work at 
the carbon black plant as confounders prob-
ably responsible for the lung cancer excess 
(Morfeld and McCunney 2010). 
Ward et al. (2010) called for enhanced 
exposure–response assessments in humans. 
Currently, a dose–response exposure analy  sis 
is under way on the U.S. carbon black cohort 
(> 5,000 production workers). An earlier 
evaluation of this cohort showed no increase 
in any type of cancer (Dell et al. 2006). 
Figure 1. Levels of analysis in epidemiologic studies 
and potential fallacies during causal inference. 
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